MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Cell Point (India) Ltd › Financials
CE
Cell Point (India) Ltd
CLOSED NSE SME Fixed Price IPO Fresh Capital Cell Point (India) IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹100
Issue Price: ₹ 100
Issue Price
₹100
Face Value
₹10
Lot Size
1,200 shares
Open Date
15 Jun 2023
Close Date
20 Jun 2023
Allotment
23 Jun 2023
Listing Date
28 Jun 2023
Exchange
NSE SME

Cell Point (India) IPO Details: Price, Dates & Financials

The Cell Point (India) IPO is a closed SME Fixed Price offer (Fresh Capital) that opened on 15 June 2023. The Cell Point (India) IPO closed on 20 June 2023, with an issue price of ₹100 per share. The Cell Point (India) IPO has a face value of ₹10 and a lot size of 1,200 shares. The Cell Point (India) IPO is listed on 28 June 2023. The Cell Point (India) IPO allotment was scheduled for 23 June 2023.

On the financial front, the Cell Point (India) IPO reported revenue of ₹22,168 for 31-Dec-22, compared with ₹27,004 for 31-Mar-22. The Cell Point (India) IPO PAT was ₹22,356 against ₹165. The Cell Point (India) IPO net worth as of 31-Dec-22 was ₹1,917.

Always verify The Cell Point (India) IPO details and GMP data with the official offer document before investing in the Cell Point (India) IPO.

Financial Summary Amount in ₹ Lakhs
Metric 31-Dec-22 31-Mar-22 31-Mar-21
Total Assets 9,064 8,270 6,531
Revenue 22,168 27,004 22,356
PAT 22,356 165 69
Net Worth 1,917 1,336 1,171
Reserves 552 1,222 1,058
Cell Point (India) IPO Financials FAQs
Revenue of Cell Point (India) (Amount in ₹ Lakhs) — 31-Dec-22: 22,168; 31-Mar-22: 27,004; 31-Mar-21: 22,356. Profit after tax (PAT) — 31-Dec-22: 22,356; 31-Mar-22: 165; 31-Mar-21: 69.
Total assets — 31-Dec-22: 9,064; 31-Mar-22: 8,270; 31-Mar-21: 6,531. Net worth — 31-Dec-22: 1,917; 31-Mar-22: 1,336; 31-Mar-21: 1,171. Reserves & surplus — 31-Dec-22: 552; 31-Mar-22: 1,222; 31-Mar-21: 1,058. (Amount in ₹ Lakhs)
The financials shown for Cell Point (India) IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.